Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Paris
- Most recent report
- 6-K, filed Oct 1, 2026
- Filings on record
- 309 filings
- On EDGAR
- CIK 1760854
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 237
- 6-K Report a foreign issuer made public elsewhere Oct 1, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 22, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 14, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 25, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 31, 2026
Prospectuses and Registrations 8 of 20
- S-8 Registration statement for an employee plan Jun 8, 2026
- FWP Free writing prospectus May 22, 2026
- 424B5 Prospectus supplement for an offering May 22, 2026
- FWP Free writing prospectus May 21, 2026
- FWP Free writing prospectus May 21, 2026
- 424B5 Prospectus supplement for an offering May 20, 2026
- S-8 Registration statement for an employee plan May 14, 2025
- F-3 Mar 6, 2025
Ownership 8 of 17
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Apr 17, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 12, 2025
- SC 13G/A Large holder reported a passive stake, amended Feb 9, 2024
- SC 13G/A Large holder reported a passive stake, amended Feb 8, 2024
- SC 13G/A Large holder reported a passive stake, amended Feb 2, 2024
- SC 13G/A Large holder reported a passive stake, amended Jan 29, 2024
Other 8 of 35
- EFFECT Notice that a registration became effective Mar 14, 2025
- CORRESP Reply to SEC staff Mar 13, 2025
- UPLOAD Comment letter from SEC staff Mar 11, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended May 19, 2022
- EFFECT Notice that a registration became effective Feb 16, 2022
- CORRESP Reply to SEC staff Feb 14, 2022
- UPLOAD Comment letter from SEC staff Feb 10, 2022
- 20-F/A Annual report, foreign issuer, amended Apr 8, 2021
Everything here comes from Nanobiotix S.A.'s own filings on SEC EDGAR. The filing list is rechecked every hour.